Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSGJ-613 in Acute Gout
NCT05588908Phase 2Unknown
- Sponsor
- 3S Guojian Pharmaceutical
- Start
- Jun 2022
- Primary completion
- Sep 2023
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of SSGJ-613 in gout, sponsored by 3S Guojian Pharmaceutical. Status: unknown.
02
Drugs
SSGJ-613
03
Conditions
gout
Beyond the preview
Go deeper on NCT05588908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05588908.